← All indications
Buruli Ulcer
A lesion in the skin and subcutaneous tissues due to infections by MYCOBACTERIUM ULCERANS. It was first reported in Uganda, Africa.
Drugs by status
Phase 3 trials (2)
Phase 2 trials (5)
Organizations
Organization Involved with Phase 3 Indications (11)
- World Health Organization
- University of Ghana
- University of Groningen
- Kwame Nkrumah University of Science and Technology
- Noguchi Memorial Institute for Medical Research
- Drugs for Neglected Diseases Initiative
- Kumasi Centre for Collaborative Research
- World Alliance for Wound and Lymphoedema Care, Switzerland
- National Buruli ulcer Control Programme, Ghana Health Service, Accra, Ghana
- University of Antwerp
- Government of Benin
Organization Involved with Phase 2 Indications (2)